Authors
Lajos Kemény
Published in
International journal of dermatology. Aug 26, 2026. Epub Aug 26, 2026.
Abstract
The treatment of inflammatory skin diseases has moved from broad immunosuppression toward mechanism-based therapy with targeted biologics and small molecules. Psoriasis exemplifies this shift: interleukin-23 (IL-23)/T helper 17 (Th17) blockade can achieve near-complete clearance, yet persistent tissue-resident memory T cells may sustain disease memory and drive relapse after treatment withdrawal. The papers highlighted in this issue link tissue memory, genotype, treatment durability, and pathway-directed therapy across different skin diseases. Together, they emphasize that precision dermatology must look beyond visible clearance toward biological remission and durable disease control.
PMID:
42644434
Bibliographic data and abstract were imported from PubMed on 26 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0